Buscar
06/05/2022
Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression
Simoes, AM, Holmstrom, MO, Aehnlich, P, Rahbech, A, Radziwon-Balicka, A, Zamora, C, Klausen, TW, Skov, V, Kjaer, L, Ellervik, C, El Fassi, D, Vidal, S, Hasselbalch, HC, Andersen, MH, Straten, PT. Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.866610. PMID:35603202. IF:7.300(Q1/3D).
01/12/2021
Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease
Isola, I, Moreno, DF, Moga, E, Mena, MP, Tovar, N, Rodriguez-Lobato, LG, Oliver-Caldes, A, Salgado, MC, Braso-Maristany, F, Yague, J, Cibeira, MT, Prat, A, Rosinol, L, Blade, J, de Larrea, CF. Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease. ANNALS OF HEMATOLOGY. 2021; 100(12)DOI:10.1007/s00277-021-04653-2. PMID:34463804. IF:4.030(Q2/5D).
01/12/2021
Extracellular Vesicles in Pulmonary Fibrosis Models and Biological Fluids of Interstitial Lung Disease Patients: A Scoping Review
d'Alessandro, M, Bergantini, L, Bargagli, E, Vidal, S. Extracellular Vesicles in Pulmonary Fibrosis Models and Biological Fluids of Interstitial Lung Disease Patients: A Scoping Review. Life-Basel. 2021; 11(12)DOI:10.3390/life11121401. PMID:34947932. IF:3.253(Q2/5D).
07/09/2021
The utility of Next Generation Sequencing for molecular diagnostics in Rett syndrome (vol 7, 12288, 2021)
Vidal, S, Brandi, N, Pacheco, P, Gerotina, E, Blasco, L, Trotta, JR, Derdak, S, O'Callaghan, MD, Garcia-Cazorla, A, Pineda, M, Armstrong, J, Cortes, R., Gallano P., Villar, Cristina. The utility of Next Generation Sequencing for molecular diagnostics in Rett syndrome (vol 7, 12288, 2021). Scientific Reports. 2021; 11(1)DOI:10.1038/s41598-021-97262-y. PMID:34493777. IF:4.997(Q2/3D).
10/09/2025
Efficacy of withdrawal or tapering of bDMARDs vs. standard regimen in axial spondyloarthritis patients: systematic review and meta-analysis informing the update of the Spanish Society of Rheumatology Guideline
Park, HS, del Campo, PD, Plana, MN, La Borda, JPY, Guerra-Rodriguez, M, Moreno, M, Cañete, JD. Efficacy of withdrawal or tapering of bDMARDs vs. standard regimen in axial spondyloarthritis patients: systematic review and meta-analysis informing the update of the Spanish Society of Rheumatology Guideline. Frontiers in Medicine. 2025; 12DOI:10.3389/fmed.2025.1621313. PMID:41001393. IF:3.000(Q1/2D).
18/06/2025
Laboratory and Clinical Practices in the Study of Coeliac Disease in Children and Adults: Recommendations from a Spanish Multicentre Survey
Aguado, R, Irure-Ventura, J, Vargas, ML, Roy, G, Barrios, Y, Martínez-Martínez, L, Rodríguez, B, Montes-Cano, MA, López-Hoyos, M, Jurado, A. Laboratory and Clinical Practices in the Study of Coeliac Disease in Children and Adults: Recommendations from a Spanish Multicentre Survey. Nutrients. 2025; 17(12)DOI:10.3390/nu17122032. PMID:40573143. IF:5.000(Q1/2D).
01/06/2025
RACE/ETHNICITY AND RHEUMATOID ARTHRITIS SEVERITY IN THE CONTEXT OF AN ACCESSIBLE PUBLIC HEALTHCARE SYSTEM
Ruiz-Esquide, V, Roig-Vilaseca, D, Mateo-Soria, L, Pérez, SH, Nack, A, Perez-Garcia, C, Park, HS, Paños, HB, Gómez-Puerta, JA, Sanmarti, R. RACE/ETHNICITY AND RHEUMATOID ARTHRITIS SEVERITY IN THE CONTEXT OF AN ACCESSIBLE PUBLIC HEALTHCARE SYSTEM. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B2454. PMID:. IF:20.600(Q1/1D).
01/10/2024
OUTCOME OF PATIENTS WITH SIGNAL-TRANSDUCER AND ACTIVATOR OF OF TRANSCRIPTION 1 MUTATIONS (STAT1) GAIN-OF-FUNCTION VARIANTS AFTER HAEMATOPOIETIC STEM CELL TRANSPLANTATION - AN IEWP/PIDTC STUDY
Buddingh, EP, Slatter, M, Becerra, JCA, Garcia, LA, von Asmuth, E, Baris, S, de la Calle-Mart n, O, Chan, A, Chan, B, Chandrakasan, S, Chellapandian, D, Dara, J, Landsverk, HCE, Farmand, S, Fasth, A, Forbes, L, Formankova, R, Grunebaum, E, Keogh, S, Kiykim, A, K hl, JS, Laberko, A, Lankester, A, Leahy, TR, Lindemans, C, Martinez, C, Mart nez-Mart nez, L, Mitchell, WG, Morris, E, Neven, B, Oved, J, Prazenicova, M, Riviere, JG, Roifman, C, G ltekin, SSK, Sedlacek, P, Shah, A, Vong, L, Leiding, J, Sch tz, C. OUTCOME OF PATIENTS WITH SIGNAL-TRANSDUCER AND ACTIVATOR OF OF TRANSCRIPTION 1 MUTATIONS (STAT1) GAIN-OF-FUNCTION VARIANTS AFTER HAEMATOPOIETIC STEM CELL TRANSPLANTATION - AN IEWP/PIDTC STUDY. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).